Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445972
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-05-31
Brief Title:
Substudy 06D Combination Therapies in Second Line 2L Gastroesophageal Adenocarcinoma MK-3475-06DKeymaker-U06
Sponsor:
Organization:
Merck Sharp Dohme LLC